|
medpundit |
||
 |
 |
|
Tuesday, March 26, 2002They have a point. The drug companies do take advantage of these things to forestall cheaper generics. It’s remarkable that Prilosec generated $4.7 billion dollars in sales in 2,000. In that same year, it’s manufacturer spent $108 million to advertise it to consumers. I guess it was well worth the cost to them. As for their “new” drug, Nexium, they are indeed trying to sell it as superior to Prilosec. I’ve seen their promotional literature. I don’t buy it, though. Like the article says, it’s just a mirror-image twin of Prilosec, and therefore can’t be expected to behave that much differently. It's not just Prilosec, though. The whole industry has a way of doing these sorts of things. When Prozac was slated to go generic, it's company came out with "Serafem" which is nothing more than Prozac renamed to be sold to women for PMS. They also came out with a once a week version of Prozac, though I don't think they've been pushing that one so hard since very few people have asked me for it. posted by Sydney on 3/26/2002 08:25:00 AM 0 comments 0 Comments: |
|
